CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

VaxServe has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Pharma Wholesale and Distribution Companies - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Stacy Kearney Bucha, General Manager.

VaxServe
Vaccination-Based Public Health Champion

VaxServe

Stacy Kearney Bucha, VaxServe | Life Science Review | Top Pharma Wholesale and Distribution CompaniesStacy Kearney Bucha, General Manager
Immunization is a fundamental component of public health, and VaxServe, a specialty vaccine distributor, has been leading the charge for the past 25 years.

Driven to serve its 65,000+ customers across various segments of healthcare, the company utilizes unmatched clinical expertise and operational excellence to keep communities across the country healthy through vaccination.

“We’re a services and solutions company dedicated to ensuring customers have an adequate supply of the vaccines they need when they need them,” said Stacy Kearney Bucha, General Manager of VaxServe. “We’re committed to helping them achieve their desired health outcomes with tools that make their business processes more efficient.”

To ensure a ready supply, the company offers access to products as well as contract fulfillment across most vaccine manufacturers so customers can purchase all vaccines from one place. Rounding out VaxServe’s offering is a roster of customized workflow solutions intended to boost program efficiencies in the areas of operations, data and analytics, and immunization advocacy.

Many large customers (retail pharmacies, health systems, employer groups, and the like) benefit from streamlining areas of their immunization business such as forecasting, ordering and shipping. With the help of meaningful analytics and insights, they can fine-tune their programs to be more efficient, thus saving time, resources and costs.

To illustrate, VaxServe supported a longstanding large, regional customer through the execution of its national growth strategy. Early on, VaxServe’s analytics team worked with the customer to generate data insights into behaviors at each site, and then provided program design and training assistance.

As a measure of success, the customer—now one of the largest immunization providers in the country—exceeded its own growth goals. The insights enabled them to make informed business decisions throughout each phase of the execution as well as improve overall program management.

Moving into the next phase of the partnership that will focus on vaccine procurement, VaxServe expects to bring even greater efficiencies to the customer’s business.

Our unique position in the U.S. as the only distributor owned by a vaccine manufacturer allows us to deliver exceptional clinical expertise and seamless operational integration to our valued customers


The company has long recognized that a one-size-fits-all doesn’t always work. Although some approaches are universal, others should be modified to align with a customer’s preferred tools and practices. In such cases, VaxServe works to integrate within preferred systems.

While VaxServe’s immunization services and solutions model may start with the customer, it certainly doesn’t end there. The company’s customer-centric approach is in tune on a broader scale with emerging public health trends and a changing industry landscape.

For example, over the past few years, what has traditionally been known as “flu season” has evolved into “respiratory season.” Along with seasonal influenza, COVID-19 and respiratory syncytial virus (RSV) infection rates are on the rise during the fall and winter months.

This dynamic has underscored the need for healthcare immunizers to adapt and adjust their immunization programming to best serve patients during high demand periods. As a result, customers have come to rely on VaxServe to ensure a more robust vaccine supply as well as help achieve efficient program operations.

Sometimes, industry changes call for new ways of reaching people who may not access health information through traditional channels. To address the gap, VaxServe partners with customers to explore new pathways that connect communities and individuals with vital information about the importance of vaccination.

This firm commitment to public health traces back to the company’s early efforts to bring meningococcal vaccines to college campuses and years later, helping to pioneer the concept of pharmacy-based vaccine clinics.

In today’s competitive market, VaxServe is much more than a distributor; it is a public health champion and preferred partner widely recognized for delivering clinical expertise and operational integration on behalf of its valued customers. A subsidiary of Sanofi, the company offers a blend of customizable solutions, exceptional service, and an uncompromising dedication to improving public health through vaccination.

VaxServe is in a unique position in the U.S. market, according to Bucha. “We are the only distributor in the country owned by a vaccine manufacturer, which allows us to deliver exceptional clinical expertise and seamless operational integration to our valued customers.”

Top 10 Pharma Wholesale and Distribution Companies - 2024
Current Issue

Company : VaxServe

Management
Stacy Kearney Bucha, General Manager

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/vaxserve